"Several people have now requested my slides on Alemtuzumab that I presented as part of the Genzyme satellite symposium at ECTRIMS. I have now loaded them onto slideshare for you to view and download."
"The aim of this presentation was to present the phase 3 trial data on Alemtuzumab in early RRMS as a therapeutic strategy that probably works by depleting circulating lymphocytes. The slides may be a little complicated as they were designed for a professional meeting. However, if you have any questions I will be around this weekend to answer them."
Labels: Alemtuzumab, ECTRIMS